Kukje Pharma Co., Ltd. (KRX:002720)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,780.00
+30.00 (0.63%)
Apr 29, 2026, 3:30 PM KST
1.81%
Market Cap 96.72B
Revenue (ttm) 175.50B
Net Income (ttm) 5.70B
Shares Out 20.36M
EPS (ttm) 280.00
PE Ratio 16.96
Forward PE n/a
Dividend 30.00 (0.63%)
Ex-Dividend Date Mar 12, 2026
Volume 77,031
Average Volume 173,025
Open 4,765.00
Previous Close 4,750.00
Day's Range 4,705.00 - 4,780.00
52-Week Range 4,050.00 - 5,470.00
Beta 0.47
RSI 47.03
Earnings Date Apr 2, 2026

About Kukje Pharma

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAID... [Read more]

Sector Healthcare
Founded 1959
Employees 248
Stock Exchange Korea Stock Exchange
Ticker Symbol 002720
Full Company Profile

Financial Performance

In 2025, Kukje Pharma's revenue was 175.50 billion, an increase of 12.16% compared to the previous year's 156.46 billion. Earnings were 5.70 billion, an increase of 9.46%.

Financial Statements

News

There is no news available yet.